Pharmacokinetic (PK)/pharmacodynamic (PD) analysis of escalating repeat doses of the AKT inhibitor GSK2141795 (GSK795) in patients (pts) with ovarian cancer.

Hatice Güngör, Hani Gabra, Emily Pickford et al.|Journal of Clinical Oncology|2011

Cited by 14